Agenda available for TVT 2015
April 30, 2015WHAT: TVT 2015 is a three-day course featuring the latest research and state-of-the-art techniques for transcatheter, aortic, and mitral valve therapies. This year's conference will emphasize advanced imaging, bioskill demonstrations, and live case transmissions featuring the world's leading experts. The agenda is now available online at: http://www.crf.org/tvt/the-conference/agenda.
Sessions showcasing the latest research will focus on research updates and new insights from mitral and transcatheter valve trials and registries. Among the highlights are:
MitraClip: World-wide Data and New Insights
- EVEREST II 5-Year Report: Beyond the Top-Line Results
Ted E. Feldman - EVEREST REALISM: High-Risk Cohort
Scott Lim - EVEREST REALISM: Non-High-Risk Cohort
Saibal Kar - New Insights From the GRASP Registry
Marco Barbanti - New Insights From the TRAMI Registry
Stephan Baldus - ACCESS EU Update
Francesco Maisano - The European Sentinel Registry
The Latest Clinical Data: Follow-up Vignettes from EU TAVR Registries
- ADVANCE
Axel Linke - UK Registry
Neil E. Moat - FRANCE 2
Helene Eltchaninoff - GARY
The Latest Clinical Data: Updates from the Randomized TAVR Trials and TVT
- PARTNER 5-Year Follow-up
E. Murat Tuzcu - CoreValve US 2-Year Follow-up
Michael J. Reardon - NOTION in All-Comers
Lars Sondergaard - Insights From the US TVT Registry
The meeting will also examine new technologies for transcatheter and mitral valve therapies including:
- Direct and indirect annuloplasty/ventriculoplasty devices (Carillon Device, Cardioband, Mitralign Procedure, Valcare Mitral Annuloplasty System, Guided Delivery Systems)
- Transcatheter mitral valve replacement devices (Tiara, Fortis, CardiaQ, Tendyne, MValve, Cephea)
- Transcatheter devices (SAPIEN XT, CoreValve Classic, LOTUS, Direct Flow, Symetis ACURATE, JenaValve, Portico, Engager, CENTERA)
- Early stage TAVR systems and novel surgical valves (Venus A, Shanghai, Trinity, Valve Medical, Thubrikar, Syntheon, Sutureless Surgical Valves)
- Cerebral embolic protection devices (Sentinel Dual Filter Device, Keystone Deflector Device,
- New access site management systems (transfemoral and transapical)
- New valvuloplasty systems and other accessories
WHEN: June 4-6, 2015
WHERE: Hilton Chicago 720 S. Michigan Ave. Chicago, Illinois
WHO: The course directors for TVT 2015 are:
Martin B. Leon, MD NewYork-Presbyterian Hospital/Columbia University Medical Center
Francesco Maisano, MD UniversitätsSpital Zürich
Nicolo Piazza, MD, PhD McGill University Health Center
Mark Reisman, MD University of Washington Medical Center/Regional Heart Center
Gregg W. Stone, MD New York-Presbyterian Hospital/Columbia University Medical Center
John G. Webb, MD St. Paul's Hospital
HOW TO REGISTER: Media may apply for registration by emailing jromero@crf.org.
For those unable to attend in person, reporters are eligible for access to Virtual TVT which provides live and on-demand viewing of the meeting sessions.
-end-
About CRFThe Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with heart disease through high quality research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. For more information, visit http://www.crf.org.
Cardiovascular Research Foundation
Related Valvular Heart Disease Articles from Brightsurf:
Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.
New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.
With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.
Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.
Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.
Is elevated systolic blood pressure associated with risk for valvular heart disease?
A group of 329,237 men and women of white Bristish ancestry with genetic data in the UK Biobank and blood pressure measurements were included in a study that examined the association between systolic blood pressure and risk of major valvular heart disease.
Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.
Impaired cellular force transmission a cause for valvular heart disease
About three per cent of the world's population is affected by valvular heart diseases.
New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.
Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.
Read More: Valvular Heart Disease News and Valvular Heart Disease Current Events
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.
New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.
With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.
Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.
Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.
Is elevated systolic blood pressure associated with risk for valvular heart disease?
A group of 329,237 men and women of white Bristish ancestry with genetic data in the UK Biobank and blood pressure measurements were included in a study that examined the association between systolic blood pressure and risk of major valvular heart disease.
Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.
Impaired cellular force transmission a cause for valvular heart disease
About three per cent of the world's population is affected by valvular heart diseases.
New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.
Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.
Read More: Valvular Heart Disease News and Valvular Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.